Dr.Randy Vogenberg, strategist & author. https://nitter.gq/t.co/VKp3iU7DlF Solutions by healthcare knowledge innovation implementation through Strategic Benefits Decisions
Joined January 2011
- Tweets6.2K
- Following205
- Followers208
- Likes3.9K
F R Vogenberg, PhD retweeted
NEW e-Books, Second Edition, 2023.
Integrated Pharmacy Benefits for Specialty Pharmaceuticals: Access and Management Pharmacy Benefits for Nonspecialty Drugs: Access and Management #pharmacy #pharmacybenefit #access #specialty #specialtydrug
accessmarketintell.com/produ…
F R Vogenberg, PhD retweeted
Updated 2023 E-books available soon: Integrated Pharmacy Benefits for Specialty and Nonspecialty drugs
#access #specialtydrug #pharmacybenefit #glossary
F R Vogenberg, PhD retweeted
Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies
#exclusion #restriction #employer #coverage
F R Vogenberg, PhD retweeted
Hospital and health system specialty pharmacy accreditation is increasing to support the growing number of patients on outpatient specialty medications
#specialtypharmacy #specialtydrug #specialtymedication
F R Vogenberg, PhD retweeted
Congratulations to all of our students who are now residents and fellows during phase I of Match Day. URI caps off a record-breaking match rate for 2023 (ranked 6th in the nation)! Check out where our students are headed below! #GoRhody #URxI
airtable.com/shrB3PVBOoFH9Bt…
F R Vogenberg, PhD retweeted
Orphan drugs or related therapies today already are nearly half of the “specialty” drugs that achieve FDA expedited or standard approval #orphandrug #FDAapproval #specialtydrug
F R Vogenberg, PhD retweeted
Persistent #GERD Symptoms Call for Change in Care Management Coverage: A Real-World Perspective for Chronic Care Policy #chroniccare
bit.ly/3R3f3Z7
F R Vogenberg, PhD retweeted
#Specialtydrug #pipeline is expected to #grow 8% per year through 2025
drugtopics.com/view/specialt…
F R Vogenberg, PhD retweeted
#researchgate noted another #reader #recognitionaward #achievement for my Feb 2009 #article on
Economic Instability and Its Impact on Decision Making in
Health Care from P&T 34(1):24-5.
Research Interest rating 2.34; Citations over 200, 12 new reads.…lnkd.in/gWxWd5PR
F R Vogenberg, PhD retweeted
Reflecting on yesterday's Employer Forum. Wrapped up the day with one last employer panel discussion with Tom Sondergeld @quietype, Randy Vogenberg @RandyIIH and Jason Parrot @vida Thanks to everyone who participated!
#mbghevents #employers
F R Vogenberg, PhD retweeted
Randy Vogenberg, PhD @RandyIIH, Kirby Eng @D2Solutions1, Jennifer Proudfit R.Ph @HSLLC_Pharma and Tracy Spencer of PSG Consulting "Weigh in on Leading Trends, New Legislation & Dysfunctions in Pharmacy Benefits."
ow.ly/2lWl50JF6TG
#mbghevents #employers
F R Vogenberg, PhD retweeted
A U.S. law goes fully into effect next year to boost the pharma supply chain, but isn't a foolproof plan for thwarting #counterfeit meds. Think of it this way: When you build a better mousetrap, you get a smarter mouse. statnews.com/pharmalot/2022/… #pharma #supplychain #HIV $GILD $JNJ
F R Vogenberg, PhD retweeted
June 22: Employer Forum on Pharmacy Benefits & Specialty Drugs, 9AM-4PM. Hear employer challenges and opportunities in driving accountability and vigilance in managing the high cost of cell and gene therapies.
Register: ow.ly/JklS50J7Unl
#mbgh #employers #specialtydrugs
F R Vogenberg, PhD retweeted
Check out the recent poll from the #EmployerProviderInterfaceCouncil looking at health weight strategies by / for #employers lnkd.in/dGdhiBZa
F R Vogenberg, PhD retweeted
Diagnostic testing is first step toward controlling infectious disease wether it’s influenza, strep, or covid. It’s wrong to think testing demand is driven by feds. It’s driven by consumers acting to seek care and obtain a definitive diagnosis to protect families and communities.
F R Vogenberg, PhD retweeted
#Leadership remains key as rapid #business #growthanddevelopment continues in many sectors. Learn more about the importance of #health as part of an effective #enterprise wide leadership #strategy by two national #CEO leaders on T…lnkd.in/d7qdetgr lnkd.in/d9s4Wm_u
F R Vogenberg, PhD retweeted
Register now on our website epicouncil.org for the next #WellSpent event on Thursday October 21st at 9:30 am ET.
Join Mayor Chip Johnson on #economicdevelopment and former #PitneyBowes CEO Michael Critelli on #culture - why both found #healthcar…lnkd.in/dRcgBQu7
F R Vogenberg, PhD retweeted
Coming up on @FaceTheNation today, I speak with host @margbrennan in extended interview on Covid and my new book “Uncontrolled Spread,” out Tuesday, with delves into the systemic woes that left U.S. excessively vulnerable to a pandemic, and how we prevent it from happening again.
@ScottGottliebMD says CDC "has a very retrospective mindset," unsuited to quick decision-making: "CDC should have raised their hand and said, we really don't have this."
cbsn.ws/3tPrhZu
F R Vogenberg, PhD retweeted
Ensemble is designed to treat both major depressive disorder & anxiety disorder. The software is accessible on computers & smartphones & guides patients through 10 wks of cognitive behavioral therapy #employers #mentalhealth @HappifyHealth @Humana @Cigna ow.ly/PPQk50FBuQe